Health and Medicine

November 18, 2011

Skeletal defects in genetic disorder

A new mouse model provides a tool for testing novel therapeutic approaches for neurofibromatosis.

By Leigh MacMillan
November 11, 2011

Averting a future oncologist shortage

Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists.

By Leigh MacMillan
Illustration of human intestinal tract
November 11, 2011

Balancing act in the gut

Vanderbilt researchers have identified an antigen important to balancing the immune response to bacteria in the gut.

By Leigh MacMillan
baby looking into the camera with uncertainty
November 10, 2011

Breastfeeding problems can be linked to a tied tongue

A simple procedure can correct ‘tongue-tie,’ a commonly missed condition that could prevent newborns from breastfeeding properly.

By VUMC News and Communications
Glowing brain
November 4, 2011

Let there be light and melatonin

Light and the hormone melatonin may play important roles in the developing brain.

By Leigh MacMillan
William Cooper
November 2, 2011

Vanderbilt study finds no heart risk in ADHD medications

Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.

By VUMC News and Communications
October 31, 2011

Lung disorder drug regimen found harmful

Longtime treatment for IPF ineffective and even dangerous.
By Kathy Whitney
October 28, 2011

Protein family key to aging linked to suppressing tumors

The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health.
By VUMC News and Communications
October 28, 2011

Vanderbilt doctors to screen patients taking statins for genetic risk factors

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
By Craig Boerner
October 27, 2011

Stopping colitis, STAT

Study suggests a new therapeutic target in ulcerative colitis.
By VUMC News and Communications
October 21, 2011

Growth factor boosts beta cells

A growth factor may help grow transplantation-quality pancreas cells for treating diabetes.
By VUMC News and Communications
October 21, 2011

Information flow reduced in psychosis

Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows.
By Leigh MacMillan
October 18, 2011

Predicting hospital readmission is risky business: study

Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers.
By Bill Snyder